OXER1: A Drug Target / Disease Biomarker (G165140)

Target Name: OXER1

NCBI ID: G165140

OXER1

OXER1: A Drug Target / Disease Biomarker

OXER1, a protein that plays a critical role in the regulation of cell division and growth, has been identified as a potential drug target or biomarker for a variety of diseases. Its function in cell division and growth regulation has been studied extensively, and its role in cancer progression has been particularly well-established.

One of the key functions of OXER1 is its role in the G1/S transition, which is the process by which a cell prepares for cell division. During the G1 phase, OXER1 helps to ensure that the cell has enough nutrients and energy for cell division. It does this by regulating the levels of the protein p21, which plays a critical role in the inhibition of cell division.

In addition to its role in cell division, OXER1 has also been shown to play a critical role in the regulation of cell growth. It does this by regulating the levels of the protein S6, which is involved in the production of matrix-extending cytoskeletal filaments that help to maintain the integrity of the cell.

Despite its importance for cell division and growth regulation, OXER1 is not well understood. Its functions and mechanisms are still the subject of ongoing research, and a great deal of work remains to be done to fully understand its role in these processes.

One of the challenges in studying OXER1 is its complex structure. While it is known to play a role in the regulation of cell division and growth, it is not clear how this is achieved or what the full range of its functions is.

In addition to its complexity, OXER1 is also prone to errors in translation, which can lead to changes in its structure and function. These errors can be caused by a variety of factors, including changes in the levels of OXER1 protein itself, as well as by interactions with other proteins or the environment.

Given its complex structure and the prone nature of its errors in translation, OXER1 is an attractive target for drug development. By inhibiting its functions or modifying its structure, researchers may be able to develop new treatments for a variety of diseases.

One potential approach to inhibiting OXER1 is through the use of small molecules. Researchers have identified a number of compounds that are able to inhibit the activity of OXER1, and these compounds have been shown to be effective in a variety of animal models of cancer.

Another potential approach to studying OXER1 is through the use of RNA interference. OXER1 is a protein that is expressed in high levels in many different types of cancer, and it is thought to play a role in the regulation of cell division and growth. By using RNA interference to knock down the levels of OXER1 in cancer cells, researchers may be able to gain new insights into its functions and mechanisms.

In addition to its potential as a drug target or biomarker, OXER1 is also of interest as a potential therapeutic target for a variety of other diseases. For example, OXER1 has been shown to play a role in the regulation of cell migration, and it is thought to be involved in the development of cancer. By targeting OXER1 with drugs or other therapeutic agents, researchers may be able to develop new treatments for a variety of diseases.

Overall, OXER1 is an important protein that has many different functions in the regulation of cell division and growth. While its mechanisms and functions are still the subject of ongoing research, its potential as a drug target or biomarker for a variety of diseases makes it an attractive target for future research.

Protein Name: Oxoeicosanoid Receptor 1

Functions: Receptor for eicosanoids and polyunsaturated fatty acids such as 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid (5-OXO-ETE), 5(S)-hydroperoxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (5(S)-HPETE) and arachidonic acid. Seems to be coupled to the G(i)/G(o), families of heteromeric G proteins

The "OXER1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OXER1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets